Induction of IL-15 mRNA and protein in A549 cells by pro-inflammatory cytokines

Immunobiology
|August 26, 1998
PubMed

Insights

Interleukin-15 (IL-15) mRNA and protein are constitutively expressed in human lung carcinoma cells. Tumor necrosis factor-alpha and IL-1 beta increase IL-15 expression, suggesting targets for cancer therapy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Interleukin-15 (IL-15) is a cytokine with functional similarities to IL-2.
  • Understanding IL-15 expression is crucial for identifying therapeutic targets.

Purpose of the Study:

  • To investigate the expression of IL-15 mRNA and protein in the A549 human lung carcinoma cell line.
  • To identify factors that modulate IL-15 expression in this cell line.

Main Methods:

  • Quantitative analysis of IL-15 mRNA expression using RT-PCR.
  • Detection of IL-15 protein in cell lysates and supernatants.
  • Treatment of A549 cells with various cytokines including TNF-alpha, IL-1 beta, and IFN-gamma, as well as growth factors like EGF and KGF.

Main Results:

  • Constitutive expression of IL-15 mRNA was observed in A549 cells.
  • Treatment with TNF-alpha or IL-1 beta (10 ng/ml) resulted in an approximate 2-fold increase in IL-15 mRNA.
  • IFN-gamma significantly affected IL-15 mRNA expression only at higher concentrations (100 ng/ml).
  • Combinations of TNF-alpha and IFN-gamma did not yield superior results compared to TNF-alpha alone.
  • EGF and KGF, individually or in combination, did not affect IL-15 expression.
  • IL-15 protein was detected in cell lysates of unstimulated cells and its levels increased upon stimulation with TNF-alpha or IL-1 beta.
  • No significant IL-15 protein was found in the cellular supernatants.

Conclusions:

  • A549 lung carcinoma cells express IL-15 constitutively.
  • IL-15 expression is upregulated by pro-inflammatory cytokines TNF-alpha and IL-1 beta.
  • These findings highlight potential pathways for modulating IL-15 in lung cancer.